marketrends - Tumblr blog

marketrends · 2 years

Text

Intravenous Immunoglobulin Market Projected to Gain Significant Value by 2031

Overview of Intravenous Immunoglobulin Market

Immunoglobulins are highly purified, sterile-specific medical therapy solutions containing gamma globulin G (IgG) in a concentration of 95% or more. These are manufactured from a highly refined pool of human plasma collected from at least 100 donors or more. Immunoglobulins can be administered through three different routes such as intramuscular, intravenous, and subcutaneous.

Read Report Overview – https://www.transparencymarketresearch.com/intravenous-immunoglobulin-market.html

The intramuscular route of administration is a relatively older method and is not preferred presently, as it is painful. Intravenous immunoglobulin has emerged as a boon in the last few decades for patients with compromised immune systems.

Intravenous Immunoglobulin Market Outlook 2031

The global intravenous immunoglobulin market was valued at US$ 11.2 Bn in 2021

It is estimated to grow at a CAGR of 7.3% from 2022 to 2031

The global intravenous immunoglobulin market is expected to reach value of US$ 20.5 Bn by the end of 2031

Request Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1930

Rise in R&D Activities in Intravenous Immunoglobulin To Fuel Market Growth

Increasing adoption of immunoglobulin, along with a surge in frequency of product launches and prompt approval from government regulatory bodies across the world is expected to fuel the demand during the forecast period. According to an October 2020 update by the National Institutes of Health, a clinical trial to test the safety, tolerability, and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral Remdesivir plus, a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, was initiated in 2020. The study was performed on hospitalized adults with COVID-19 in the U.S., Mexico, and 16 other countries on five continents.

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, sponsored and funded the phase 3 trial, called Inpatient Treatment with Anti-Coronavirus Immunoglobulin, or ITAC. The antibody solution that was tested in the ITAC trial is anti-coronavirus hyperimmune intravenous immunoglobulin or hIVIG. Moreover, the rise in the number of government initiatives supporting the usage of the intravenous mode of delivery for some medications propels the global market. For instance, in June 2021, the Ministry of Health and Family Welfare of Karnataka, India, decided to procure an intravenous immunoglobulin (IVIG) drug worth more than INR 10 Cr for emergency use among children.

Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1930

Surge in incidence of Primary Immunodeficiency Diseases to Drive Global Market

In terms of indication, the global intravenous immunoglobulin market has been classified into chronic inflammatory demyelinating polyneuropathy (CIDP), primary humoral immunodeficiency, idiopathic thrombocytopenic purpura (ITP), Guillain-Barre syndrome, myasthenia gravis, multifocal motor neuropathy (MMN), Kawasaki disease, hypogammaglobulinemia, chronic lymphocytic leukemia, and others. The hypogammaglobinemia segment dominated the global market in 2021. This can be attributed to increase in incidence of primary immunodeficiency diseases (PID) across the globe. It is the most common chronic immune defect in patients with lymphoproliferative disorders (LPDs).

Preference for Hospital Treatment to Propel Demand for Intravenous Immunoglobulin in Hospitals

Based on end-user, the global intravenous immunoglobulin market has been divided into hospitals, clinics, and home care. The hospitals segment dominated the global intravenous immunoglobulin market in 2021, owing to rise in the number of patients opting for hospital treatment rather than standalone clinics. Moreover, patients receiving IVIG infusions at home have improved quality of life, as they get better control over day-to-day activities. For instance, IVIG infusions at home care have reduced scheduling clashes for patients.

Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1930

COVID-19 Pandemic to Fuel Growth of Intravenous Immunoglobulin Market

The COVID-19 pandemic in its later phase is more likely to propel the growth of the global intravenous immunoglobulin market. December 2020 published article titled, 'COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience', stated that out of 100 individuals with primary immunodeficiency (PID), symptomatic secondary immunodeficiency (SID), autoinflammatory diseases, and C1 inhibitor deficiency, 70% were infected with the SARS-CoV-2 virus and 59% were admitted to hospitals, with 8% admitted to intensive care units. Therefore, an increase in immune-deficient individuals who are at higher risk of being infected with COVID-19 is likely to propel the global intravenous immunoglobulin market during the pandemic.

According to an October 2020 published article titled, 'The uSAGE of Intravenous Immunoglobulin Gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial', the administration of intravenous immunoglobulin in patients with severe COVID-19 infection was expected to enhance the clinical outcome and aid in a significant reduction of the mortality rate due to SARS-CoV2 viral infection. Hence, the global market is likely to witness strong growth during the pandemic.

Analysis of Key Players in Global Intravenous Immunoglobulin Market

This report profiles key players in the global intravenous immunoglobulin market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The global intravenous immunoglobulin market is highly fragmented, with the presence of several international as well as regional players. Leading players operating in the global intravenous immunoglobulin market are Baxalta Incorporated, Biotest AG, China Biologic Products, Inc., CSL Behring LLC, Grifols S.A., Kedrion S.p.A., LFB Biomedicaments S.A., Octapharma AG, and Sanquin Plasma Products B.V., among others.

Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1930

The growing burden of target diseases such as primary immunodeficiency diseases is expected to fuel the growth of the market in the region. According to the National Institute of Allergy and Infectious Diseases, in 2020, more than 400 types of PIDs were diagnosed in the U.S., with more than 500,000 people affected by PIDs.

According to the USIDNET Registry, 2020, the frequency of severe combined immunodeficiency (SCID) among the population of the U.S. stood at 355. Moreover, increase in research & development activities and rapid product approvals are projected to fuel the growth of the intravenous immunoglobulin market growth in North America.

More Trending Reports by Transparency Market Research –

India Animal Health Care Market: https://www.transparencymarketresearch.com/india-animal-health-care-market.html

Albumin Market: https://www.transparencymarketresearch.com/global-albumin-market.html

Saudi Arabia Veterinary Therapeutics Market: https://www.transparencymarketresearch.com/ksa-veterinary-therapeutics-market.html

Geriatric Care Services Market: https://www.transparencymarketresearch.com/geriatric-care-services-market.html

Malaysia Medical Tourism Market: https://www.transparencymarketresearch.com/malaysia-medical-tourism-market.html

Gene Therapy Market: https://www.transparencymarketresearch.com/gene-therapy-market.html

Pulmonary Arterial Hypertension Market: https://www.transparencymarketresearch.com/pulmonary-arterial-hypertension-therapeutics.html

Electrosurgery Market: https://www.biospace.com/article/electrosurgery-market-growth-prospects-trends-and-forecast-up-to-2031/

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email: [email protected]

#Intravenous Immunoglobulin Market #Intravenous Immunoglobulin Market Share #Intravenous Immunoglobulin Market Size #Intravenous Immunoglobulin Market Trends #Intravenous Immunoglobulin Market Analysis

0 notes

marketrends · 2 years

Text

EMEA Meningitis Diagnostic Testing Market Size to Grow at a Solid CAGR of 3.7% Between 2021 and 2031

Europe and Middle East & Africa Meningitis Diagnostic Testing Market: Introduction

According to the report, the meningitis diagnostic testing market in EMEA was valued at US$ 55.95 Mn in 2020 and is projected to expand at a CAGR of 3.7% from 2021 to 2031. Awareness about meningitis, its symptoms, and medications is most important for patients. Several meningitis disease awareness programs have been initiated to increase awareness among people.

In Africa, the Meningitis Vaccine Project (MVP) was an international partnership that began in 2010 and focused on the development, testing, licensure, and widespread introduction of a conjugate vaccine with the promise of protecting millions of lives from group A meningococcal meningitis. Increase in awareness about new meningitis diagnosis test, healthcare techniques, and disease indication is projected to boost the growth of the market in EMEA during the forecast period.

Request Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84238

Moreover, surge in global healthcare expenditure led by rise in disposable income is anticipated to drive the meningitis diagnostic testing in the near future. Rise in healthcare expenditure led by surge in awareness about different healthcare programs and availability of cost-effective diagnostic methods are expected to fuel the growth of the meningitis diagnostic testing market in EMEA during the forecast period.

Lateral Flow Assay Segment to Lead Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market

In terms of product type, the meningitis diagnostic testing market in EMEA has been classified into latex agglutination tests, lateral flow assay, PCR assay, ELISA tests, culture test, and others. The lateral flow assay segment is projected to account for major share of the meningitis diagnostic testing market in EMEA during the forecast period.

The growth of the segment can be attributed to low cost of lateral flow assays (US$ 2 per test in low-income countries and US$ 5 per test in high-income countries), rapid & reliable results in near-patient settings, and lack of requirement for any lab infrastructure or cold chain transport. The test is utilized to detect bacterial meningitis. Rise in prevalence of bacterial meningitis is expected to propel the segment during the forecast period.

Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=84238

Preference for Syndromic Full Multiplex Panel

Based on panel type, the meningitis diagnostic testing market in EMEA has been bifurcated into syndromic full multiplex panel and low plex panel. The syndromic full multiplex panel segment held major market share in 2020. Increase in use of syndromic full multiplex panel in the diagnosis of different types of meningitis is likely to augment the segment during the forecast period. Instant identification of different types of meningitis in diagnostic labs using syndromic full multiplex panels has allowed higher response time and shorter waiting time.

Easy availability of syndromic full multiplex panels and rise in use of this type of panel in meningitis diagnosis are projected to propel the syndromic full multiplex panel segment over the next few years.

Hospitals to be Major End-user

In terms of end-user, the meningitis diagnostic testing market in EMEA has been divided into hospitals, diagnostic laboratories, and others. Meningitis is a fatal disease that requires immediate care. Therefore, increase in number of hospital visits and rise in prevalence of meningitis are projected to boost the growth of the hospitals segment during the forecast period. The diagnostic centers segment held the second largest share of the market in 2020. Diagnostic centers are specially meant only for disease detection. These are well equipped with sophisticated instruments, hence people in developing and under-developed countries prefer diagnostics centers.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84238

Europe to Lead Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market

Europe dominated the meningitis diagnostic testing market in EMEA in 2020, accounting for 60.7% market share. The availability of rapid diagnostic tests, routine vaccination programs to prevent meningitis, and increase in patient awareness are projected to drive the market in Europe during the forecast period.

Middle East & Africa is a rapidly expanding market for meningitis diagnostic testing. The market in the region is anticipated to expand at a high CAGR from 2021 to 2031 due to rise in demand for meningitis diagnostic testing.

Competition Landscape

The meningitis diagnostic testing market in EMEA is fragmented due to the presence of a large number of leading players. Key players operating in the market include Thermo Fisher Scientific, Inc., Abbott Laboratories, BioFire Diagnostics, Bio-Rad Laboratories, Inc., ELITechGroup, Fast Track Diagnostics Ltd. (Siemens Healthineers), IMMY, Nanosphere (Luminex Corporation), Seegene, Inc. and Qnostics.

More Trending Reports by Transparency Market Research –

Pulmonary Drug Delivery Devices Market: https://www.transparencymarketresearch.com/pulmonary-drug-delivery-devices-market-2018-2026.html

Lactate Meter Market: https://www.transparencymarketresearch.com/lactate-meters-market.html

Defibrillators Market: https://www.transparencymarketresearch.com/defibrillators-market.html

Coated Endotracheal Tube Market: https://www.transparencymarketresearch.com/coated-endotracheal-tubes-market.html

Surgical Microscopes Market: https://www.transparencymarketresearch.com/surgical-microscopes-market.html

Pericardial Patches Market: https://www.transparencymarketresearch.com/pericardial-patches-market.html

Surgical Robots Market: https://www.transparencymarketresearch.com/surgical-robots-market.html

Neurostimulation Devices Market: https://www.transparencymarketresearch.com/neurostimulation-devices-market.html

About Us

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

#EMEA Meningitis Diagnostic Testing Market #EMEA Meningitis Diagnostic Testing Market Share #EMEA Meningitis Diagnostic Testing Market Size #EMEA Meningitis Diagnostic Testing Market Analysis #EMEA Meningitis Diagnostic Testing Market Forecast

0 notes

marketrends · 2 years

Text

Shock Wave Therapy Device Market Trends, On-going Demand, Opportunities, Segmentation, and Forecast till 2025

Transparency Market Research (TMR) has published a new report titled “Shock Wave Therapy Device Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report the global shock wave therapy device market was valued at US$ 91.6 Mn in 2016 and is projected to expand at a CAGR of 5.0% from 2017 to 2025. The report suggests that increase in number of bone injuries and rise in demand for chair time optimization is projected to boost the shock wave therapy device market during the forecast period (2017 to 2025). North America and Europe are projected to dominate the global market owing to increase in adoption of shock wave therapy device for treatment by orthopedic doctors and patients. The market in Asia Pacific is projected to expand at exponential CAGR during the forecast period. Growth of market in Asia Pacific is attributed to large number of private clinics and hospitals, rise in the number of geriatric population requiring physiotherapy services after bone surgery, and increase in adoption of sports activities among the youth. The market for shock wave therapy device in Latin America is likely to expand at moderate growth rate during the forecast period.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13457

Value Added Features in Shock Wave Therapy Device to Fuel Global Market Expansion

The global shock wave therapy device market is projected to be driven by value added features offered by various shock wave therapy device companies to streamline the day-to-day work flow and increase revenue of practices. The shock wave therapy device provides a wide range of features and benefits from patient pain healing remedies to treatment procedures at varied frequencies. These features help physicians and nurse to streamline physiotherapy activities required for the patients to maintain their daily routine efficiently and effectively. Key players offering shock wave therapy devices are coming up with value added features such as effective probes, sensors, ultrasound devices, laser connectivity, effective modality features, and imaging modules, thereby reducing the overall operating cost and improving the effectiveness and efficiency of physiotherapy. These companies are focusing on developing combined shock wave therapy facilities in their system to effectively integrate therapy or treatment procedure along with imaging tools such as cameras, digital radio-graphs, high sensors, and patient education & awareness programs. These value added features save operational time of physicians and help improve pain management performance.

Radial or Ballistic Shock Wave Generation is Projected to be a Highly Lucrative Deployment Mode

Focused shock wave generation based technology is commonly used in the pain management therapy. This technology is associated with electromagnetic, electrohydraulic, and piezoelectric methodology. Price of this technology is based on perpetual license model. The radial or ballistic shock wave generation technology enables the usage of shock wave therapy device in low frequency clinical applications. This allows healing of extreme pain in musculoskeletal structures and assures 90% recovery. These attributes are likely to propel the segment during forecast period. Radial or ballistic shock wave generation based technology addresses specific challenges faced during the treatment procedure due to its low frequency shock wave therapy. The radial or ballistic shock wave generation technology provides pain relief, increase in range of motion and muscular strength in patients who have undergone bone injury.

Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=13457

Orthopedic and Urology Application of Shock Wave Therapy Device Leads the Market

The report offers detailed segmentation about applications of shock wave therapy device into orthopedic, cardiology, erectile dysfunction and urology. The orthopedic and urology segment is expected to account for a leading share of the market during the forecast period (2017-2025). High share of the orthopedic and urology segments are attributed to rise in orthopedic surgeries, prevalence of kidney stones among global population, and increase in demand for lithotripsy by physicians and patients contribute to the high market share of the orthopedic and urology segments. Furthermore, availability of various reimbursement and Medicare benefits for patients for the treatment of diseases is projected to propel the orthopedic & urology segments.

Hospitals Segment to Dominate the Market During the Forecast Period

The hospitals segment accounted for a leading share of the global shock wave therapy device market. It is estimated to gain market share by the end of 2025. The segment is expected to expand at a CAGR of more than 5% during the forecast period. Expansion of the specialized pain management service, increase in number of orthopedic patient footfall in hospitals, and adoption of digital platforms for marketing pain management practices has contributed to the dominant share of the segment. Increase in number of multinational hospital chains and high digitization budgets are likely to drive the hospitals segment during the forecast period. High prevalence and incidence rates of bone injuries and kidney stones and increase in number of cases of erectile dysfunction across the global has increased patient flow to clinics. These factors are expected to fuel the clinic segment between 2017 and 2025.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=13457

Asia Pacific to Create Business Development Opportunities

North America and Europe accounted for a major share of the global shock wave therapy device market in 2016 and are likely to gain their share by 2025. High adoption of digital platforms for pain management, rise in health care budgets, and government initiative to promote minimally invasive surgery techniques have contributed to the dominant market share of these regions. Asia Pacific is projected to be the most lucrative market, with highest attractiveness index. The market in the Asia Pacific region is projected to expand at a CAGR of over 6% during the forecast period. Expansion of the market in the region is due to large number of clinics in emerging countries such as India and China, well established health care facilities and high adoption of digital health care technology in countries such as Japan, Australia & New Zealand, Malaysia, and Singapore. Market in Latin America is anticipated to expand at a moderate growth rate during the forecast period.

Key trend of research and development among the leading Players to Increase Geographic Presence has been observed in last few years.

The report also provides profiles of leading players operating in the global shock wave therapy device market. EMS Electro Medical Systems S.A., BTL Corporate, Dornier MedTech GmbH, and Zimmer MedizinSysteme GmbH are some leading players operating in the global shock wave therapy device market. These companies are engaged in increasing their geographic presence through strategic acquisition and collaboration with other leading players. In October 2017, Dynatronics Corporation partnered with Zimmer MedizinSysteme GmbH (Zimmer) for exclusive distribution of select therapy equipment in the U.S. Other prominent players operating in the global shock wave therapy device include Siemens AG, Boston Scientific Corporation, and Guangzhou Longest Science & Technology Co.

More Trending Reports by Transparency Market Research –

Syringes Market: https://www.transparencymarketresearch.com/europe-syringes-market.html

Varicose Vein Treatment Market: https://www.transparencymarketresearch.com/varicose-vein-treatment-market.html

Audiological Devices Market: https://www.transparencymarketresearch.com/audiological-devices-market.html

Breast Reconstruction Market: https://www.transparencymarketresearch.com/breast-reconstruction-market.html

Roadside Drug Testing Devices Market: https://www.transparencymarketresearch.com/us-roadside-drug-testing-devices-market.html

Retractable Needles Market: https://www.transparencymarketresearch.com/retractable-needles-market.html

Sensor Based Smart Catheters Market: https://www.transparencymarketresearch.com/sensor-based-smart-catheters-market.html

Hearing Aids Market Revenue: https://www.transparencymarketresearch.com/hearing-aid-market.html

About Us

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

#Shock Wave Therapy Device Market #Shock Wave Therapy Device Market Analysis #Shock Wave Therapy Device Market Growth #Shock Wave Therapy Device Market Trends #Shock Wave Therapy Device Market Outlook

0 notes

marketrends · 2 years

Text

Biosimilars Market Overview and Forecast Analysis up to 2031

Biosimilars Market: Introduction

Biosimilars can be defined as a biologic medical product, which is considered to be similar to already approved biologic. These biosimilars are approved based on their efficacy, quality, safety, and the same standards of pharmaceutical quality that apply to all biologic medicines. Chronic disease prevalence has been increasing significantly at the global level. This necessitates the need for affordable treatment, contributing to the growth of the biosimilars market.

Europe dominated the biosimilars market in 2018 and the trend is anticipated to continue during the forecast period. The strong growth of the market in the region can be attributed to increase in approvals of biosimilars in Europe. For instance, in 2018, over 16 biosimilars were approved in the region for various indications, including oncology, chronic diseases, and autoimmune diseases.

Patent Expiry of Major Biologics to Accelerate Market Growth

Patent expiries of major biologics are expected to contribute to the growth of the biosimilars market.

For instance, the U.S. patent of MabThera/Rituxan (rituximab), a biologic manufactured by Roche, expired in 2016. This provides ample growth opportunities to manufacturers of rituximab biosimilar, such as Amgen, Boehringer Ingelheim, and Pfizer. In addition, a range of top selling brands including Herceptin, Enbrel, Humalog, and Aranesp are anticipated to lose patents during the forecast period.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=118

Increase in Approvals of Biosimilars to Drive Global Market

The U.S. has witnessed a wave of biosimilar approvals in 2019. According to the Antibody Society in the U.S., over 16 antibody biosimilar therapeutics were approved from 2015 to 2019. Drugs approved in 2019 include Trazimera, Kanjinti, and Ruxience.

As per the FDA’s Biosimilars Action Plan, new policies are being made to make the development of biosimilars more efficient and provide significant opportunities to biosimilar manufacturers. This is anticipated to propel the rate of biosimilar approvals in the U.S., contributing to the growth of the biosimilars market.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=118

High Demand for Recombinant Non-glycosylated Protein Biosimilars

In terms of product, the recombinant non-glycosylated proteins segment is likely to account for a major share of the global biosimilars market. Moreover, the insulin sub-segment of the recombinant non-glycosylated proteins segment dominated the market in 2018. It is likely to grow at a high CAGR during the forecast period, due to increase in prevalence of diabetes globally. According to the International Diabetes Federation, over 463 million adults aged between 20 years and 79 years lived with diabetes in 2019.

Biosimilars for Oncology Indication to Dominate Global Market

In terms of indication, the global biosimilars market has been divided into chronic diseases, oncology, autoimmune diseases, infectious diseases, blood disorders, growth hormone deficiency, and others. The oncology segment held the largest market share in 2018 and the trend is anticipated to continue during the forecast period. The robust growth of the segment can be attributed to rise in prevalence of cancer cases globally. According to the World Cancer Research fund, over 18 million cancer cases were reported in 2018. In addition, the patent expiration of a range of cancer biologic drugs, leading to the growing usage of biosimilars, owing to their lower costs contributes to the growth of the segment in the forecast period.

Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=118

Biosimilars Market: Prominent Regions

In terms of region, the global biosimilars market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe dominated the global biosimilars market in 2018. This can be attributed to the significant price reduction in biosimilars as compared to biologics, and country policies in Europe enabling the penetration of biosimilars to enhance patient access to affordable treatment, contributes to the growth of the market in Europe.

The biosimilars market in Asia Pacific is likely to expand at a rapid CAGR from 2019 to 2027. Increase in population of Asian countries, rise in urbanization, surge in aging population, lifestyle changes, and growing incidence of non-communicable diseases such as diabetes, cancer, and autoimmune diseases are driving the biosimilars market in Asia Pacific. Furthermore, various countries in South Asia have been assigning a major portion of their medical research budget for the development of biosimilars.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=118

Biosimilars Market: Key Strategies

The global biosimilars market is consolidated in terms of number of players. Key players operating in the global biosimilars market include Pfizer, Inc., Intas Pharmaceuticals Ltd., Biocon, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH (A Novartis Division), Celltrion Inc., Amgen, Inc., STADA Arzneimittel AG, and Apotex Inc. (Apobiologix).

These players have adopted various strategies such as product portfolio expansion, investment in research & development, collaborations, and product launches to establish a strong geographic presence. For instance, in November 2019, Pfizer received the U.S. FDA approval for its ABRILADA, a biosimilar to Humira, for the treatment of patients with rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis, and plaque psoriasis.

More Trending Reports by Transparency Market Research –

Glioblastoma Multiforme Treatment (GBM) Market: https://www.transparencymarketresearch.com/pipeline-review-of-glioblastoma-treatment-market.html

Pain Management Devices Market: https://www.transparencymarketresearch.com/pain-management-drugs-devices.html

Traditional Chinese Herbal Medicine for Face-care Market: https://www.transparencymarketresearch.com/asia-pacific-traditional-chinese-herbal-medicine-for-face-care-market.html

Drug Device Combination Products Market: https://www.transparencymarketresearch.com/drug-device-combination.html

Unicompartmental Knee Prosthesis Market: https://www.transparencymarketresearch.com/unicompartmental-knee-prostheses-market.html

Polymerase Chain Reaction Market: https://www.transparencymarketresearch.com/pcr-technologies.html

Prefilled Syringes Market: https://www.transparencymarketresearch.com/prefilled-syringes-market.html

Hyaluronic Acid Products Market: https://www.transparencymarketresearch.com/hyaluronic-acid-products-market.html

About Us

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

0 notes

marketrends · 2 years

Text

Increase in global prevalence of chronic diseases that require novel drug delivery technologies for treatment is expected to boost the market. Emergence of advanced technologies and surge in research & development activities are some factors that are expected to propel the market.

#Drug Delivery Technology Market #Drug Delivery Technology Market Share #Drug Delivery Technology Market Analysis #Drug Delivery Technology Market Growth

0 notes

marketrends · 2 years

Text

The global multiple sclerosis drugs market is expected to grow at a CAGR of 5.9% during the forecast period. The growth of the market can be primarily attributed to the significant rise in the number of research projects focusing on the discovery of new multiple sclerosis drugs with improved efficacy.

#Multiple Sclerosis Drugs Market #Multiple Sclerosis Drugs Market Share #Multiple Sclerosis Drugs Market Analysis #Multiple Sclerosis Drugs Market Forecast

0 notes

marketrends · 2 years

Text

As per the latest report by Transparency Market Research (TMR), the global market for human growth hormone is likely to see strong growth in the coming years. The market is estimated to increase to 6.2% CAGR. The global market for human growth hormone is also estimated to generate US$ 5,261.5 million revenue by 2026 end.

#Human Growth Hormone Market #Human Growth Hormone Market Share #Human Growth Hormone Market Size #Human Growth Hormone Market Analysis #Human Growth Hormone Market Forecast

0 notes

marketrends · 2 years

Text

Bioinformatics Market Expected to Witness a Sustainable Growth by 2028

Bioinformatics Market: Introduction

According to the report, the global bioinformatics market was valued at US$ 24.7 Bn in 2020 and is projected to expand at a CAGR of 5.9% from 2021 to 2028. Bioinformatics is used to manage the data gathered from research & development projects in the biopharmaceutical, life sciences, and biotechnology industries. Growth of the bioinformatics market is driven by rise in applications of IT in the healthcare sector, along with robust technological advancements. The usage of information technology or IT has enabled easy storage, processing, access, and retrieval of data.

Additionally, the demand for advanced treatment of several diseases and effective preventive solutions is rising. Hence, healthcare professionals focus on research & development projects. Moreover, surge in R&D activities has led to rise in data generation, which increases demand for efficient technology for data management in the healthcare sector.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=656

Usage of Bioinformatics in High Throughput Screening

The high throughput screening is an emerging bioinformatics field that performs biological tests at high speed with the help of data processing software, sensitive detectors, and liquid handling devices. Increase in importance of high throughput screening in drug discovery is likely to drive the global bioinformatics market over the next few years.

Platforms Segment to Dominate Global Market

The global bioinformatics market has been segmented into services, tools, and platforms. These are commercially available for the purpose of processing the data obtained from various research & development projects employing bioinformatics. In terms of consumption, the platforms segment dominated the global market in 2020, accounting for leading share. The growth of the segment can be attributed to rise in usage of bioinformatics in the process of drug discovery and increase in research & development activities. However, the services segment is projected to dominate the global market during the forecast period.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=656

Molecular Medicine Segment to Dominate Market

Bioinformatics has applications in preventive medicine, molecular medicine, gene therapy, drug development, and others. Other application areas include forensic analysis of microbes, genetic research for antibiotic resistance, and veterinary science. The molecular medicine segment accounted for the largest market share in 2020. The drug development segment is anticipated to expand at the highest CAGR from 2021 to 2028.

North America to Dominate Global Market

In terms of region, the global bioinformatics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global bioinformatics market in 2020, followed by Europe. Availability of developed technology, structured regulatory framework, higher adoption rate of new technology, and significant investment in research & development by companies boost the growth of the bioinformatics market in North America and Europe. Asia Pacific is a lucrative market for bioinformatics. Factors such as surge in government initiatives to boost biotechnology research & development activities in respective country, increase in funding, rise in awareness about bioinformatics, and surge in literacy rate are expected to fuel the growth of the bioinformatics market in Asia Pacific.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=656

Competition Landscape

The global bioinformatics market is fragmented in terms of number of players. Key players in the global market include Accelrys, Inc., ID Business Solutions, Ltd., Affymetrix, Inc., CLC bio A/S, Agilent Technologies, Inc., GenoLogics Life Sciences Software, Inc., Life Technologies Corporation, and Illumina, Inc.

More Trending Reports by Transparency Market Research –

Albumin Market: https://www.transparencymarketresearch.com/global-albumin-market.html

Liquid Filled Hard Capsules Market: https://www.transparencymarketresearch.com/liquidfilled-hard-capsules-market.html

Antihypertensive Drugs Market: https://www.transparencymarketresearch.com/antihypertensive-drugs-market.html

FFPE Tissue Samples Market: https://www.transparencymarketresearch.com/ffpe-tissue-samples-market.html

Radiopharmaceutical Theranostics Market: https://www.transparencymarketresearch.com/radiopharmaceutical-theranostics-market.html

Advanced Glycation End Products Market: https://www.transparencymarketresearch.com/advanced-glycation-end-products-market.html

Liquid Filled Hard Capsules Market: https://www.transparencymarketresearch.com/liquidfilled-hard-capsules-market.html

Fibrinogen Concentrates Market: https://www.transparencymarketresearch.com/fibrinogen-concentrates-market.html

About Us

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

#Bioinformatics Market #Bioinformatics Market Share #Bioinformatics Market Size #Bioinformatics Market Analysis #Bioinformatics Market Forecast

0 notes

marketrends · 2 years

Text

#Non-Hodgkin Lymphoma Therapeutics Market #Non-Hodgkin Lymphoma Therapeutics Market Share #Non-Hodgkin Lymphoma Therapeutics Market Size #Non-Hodgkin Lymphoma Therapeutics Market Analysis #Non-Hodgkin Lymphoma Therapeutics Market Forecast

0 notes

marketrends · 2 years

Text

Vaccines Market Estimated to Expand at a Robust CAGR by 2025

The demand within the global market for vaccines has been rising on account of advancements in the field of medical therapy and disease prevention, finds Transparency Market Research (TMR). There is a high probability of new vendors emerging in the global vaccines market in the years to come. The historic trends have been suggestive of the opportunities that have aided market growth in recent times.

The leading vendors in the global vaccines market have engaged in core research and development in order to earn increased revenues. Furthermore, these vendors are projected to invest in new vaccination lines to elevate their standards of production.

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21

The competition in the global market for vaccines is expected to intensify in the years to come. This is because a large number of established players are moving neck and neck in the quest to develop more effective vaccines.

The competition in the global vaccines market has further escalated on account of the emergence of newbie vendors in the global vaccines market. There is a heavy possibility of strategic alliances being formed in the global vaccines market. Some of the key players in the global vaccines market are CSL Ltd, Janssen Pharmaceutical Company, GlaxoSmithKline plc., Pfizer, Inc., Mitsubishi Tanabe Pharma Corporation, and Sanofi Pasteur SA.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=21

Transparency Market Research (TMR) predicts that the global market for vaccines would expand at a healthy CAGR of 6.0% over the period between 2017 and 2025. Furthermore, the cumulative value of the global vaccines market is projected to reach US$ 48.0 Bn by 2025-end, rising up from a value of US$ 28.0 Bn in 2016. On the basis of vaccine type, the market for toxoid vaccines is expected to expand in the years to come. Based on geography, the market for vaccines in Europe is projected to accumulate humongous revenues in the years to come.

Availability of Vaccines for Kids to Propels

The global market for vaccines caters to the masses of all age groups, including children. The need to vaccinate children in order to prevent them from serious diseases is being felt across the world. Hence, the global vaccines market is projected to expand alongside advancements in the field of disease care and paediatrics.

Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=21

Furthermore, the market for vaccines has also expanded on account of the growth of new and advanced facilities across medical facilities such as healthcare centers and hospitals. Doctors and medical practitioners recommend all essential vaccines for people of various age groups which in turn pushes market growth.

Emergence of New Selling Points to Aid Market Growth

The global market for vaccines has been expanding alongside increase in the number of distribution channels for vaccines. The popularity of institutional sales for the purposeof vaccination has created stellar opportunities for growth within the global market. Moreover, hospitals now have dedicated sections for vaccination and treatment which has in turn propelled market demand.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=21

Medication and injective vaccines are also available across retail pharmacies, and this another key consideration from the perspective of market growth. The revenue index of the global vaccines market is projected to reach new volumes in the years to come.

More Trending Reports by Transparency Market Research –

Nanotechnology Drug Delivery Market: https://www.transparencymarketresearch.com/nanotechnology-drug-delivery.html

Veterinary Dermatology Drugs Market: https://www.transparencymarketresearch.com/veterinary-dermatology-drugs-market.html

Liposome Drug Delivery Market: https://www.transparencymarketresearch.com/liposome-drug-delivery-market.html

Microbiology Culture Market: https://www.transparencymarketresearch.com/microbiology-culture-market.html

Empty Capsules Market: https://www.transparencymarketresearch.com/empty-capsules-market.html

Opioid Tolerance Treatment Market: https://www.transparencymarketresearch.com/opioid-tolerance-treatment-market.html

CBD Hemp Oil Market: https://www.transparencymarketresearch.com/cbd-hemp-oil-market.html

TNF Inhibitors Market: https://www.transparencymarketresearch.com/tnf-inhibitors-market.html

About Us

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

#Vaccines Market #Vaccines Market Share #Vaccines Market Size #Vaccines Market Analysis

0 notes